Loading clinical trials...
Loading clinical trials...
The purpose of this study is to develop and evaluate a blood test for pregnant women for detection of fetal aneuploidy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Roche Sequencing Solutions
NCT07643896 · Pregnant Individuals, Aneuploidy, and more
NCT06783725 · Down Syndrome, Down Syndrome (Trisomy 21)
NCT07234695 · Down Syndrome, Down Syndrome (DS), and more
NCT07227116 · Complex Aneuploidy, Chaotic Aneuploidy
NCT07036536 · Infertility, Mosaicism, and more
East Bay Perinatal Medical Associates
Oakland, California
Prenatal Diagnosis of Northern California
Sacramento, California
University of California - San Diego
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions